| Literature DB >> 19255868 |
Thore C Brink1, Christian Regenbrecht, Lloyd Demetrius, Hans Lehrach, James Adjaye.
Abstract
The process of aging is complex involving numerous factors centered on transcriptional changes with advanced age. This study was aimed at elucidating mechanisms involved in mouse aging by conducting both gene expression and biochemical analyses on isolated mouse brain, heart and kidney. The gene expression analysis was not aimed at solely highlighting age-related transcriptional changes but also revealing regulated biological processes, cellular compartments, signaling and metabolic pathways. We have uncovered a conserved increase in the expression of genes mediating immune responses in all the tissues analyzed. In addition, elevated levels of lipid hydroperoxides (LPO)—an indicator of increased levels of radical oxygen species, implicate an oxidative stress-mediated activity of NF-kB signaling. In summary, these results suggest that transcriptional changes are most probably the downstream effect of environmental and endogenous factors constantly affecting the organism during its lifetime. In addition, we propose LPO as a potential biomarker of aging.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19255868 PMCID: PMC2778679 DOI: 10.1007/s10522-009-9219-1
Source DB: PubMed Journal: Biogerontology ISSN: 1389-5729 Impact factor: 4.277
Fig. 1Results of the global expression data analysis. The figure shows a the sample clustering and b the corresponding correlation coefficients (R 2) derived from whole genome gene expression analyses for young and aged mouse whole brain, heart and kidney. Correlation coefficients are colored as follows: red = 0.90–1.00, orange = 0.80–0.90, white = 0.70–0.80 and gray <0.70. c Confirmation of microarray-derived data for relevant genes by Real-Time PCR. d Western blot analysis of complement component C3 on homogenates derived from brain, heart and kidney tissues (y: young; a: aged). In all three tissues we see an increased protein expression in the aged tissue compared to the respective young control. GAPDH was used as loading control (color figure in online)
Number of age-regulated genes in the three tissues
| Fold change | Brain | Heart | Kidney | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Up | Down | Total | Up | Down | Total | Up | Down | Total | |
| >1.3 | 581 | 247 | 828 | 569 | 421 | 990 | 1,112 | 432 | 1,544 |
| >1.5 | 232 | 64 | 296 | 309 | 220 | 529 | 722 | 173 | 895 |
| >2.0 | 46 | 8 | 54 | 127 | 68 | 195 | 302 | 37 | 339 |
Overrepresentation of immune-related genes
| Name | Accession | Description | Ratio | ||
|---|---|---|---|---|---|
| Brain | Heart | Kidney | |||
| Igk-C | XM_132633 | Immunoglobulin kappa chain, constant region | 2.66 | 1.31 | 3.58 |
| Slp | NM_011413 | Sex-limited protein | 2.12 | 2.48 | 1.89 |
| Slp | NM_011413 | Sex-limited protein | 2.05 | 1.96 | 2.03 |
| C4 | NM_009780 | Complement component 4 (within H-2S) | 1.77 | 1.98 | 1.95 |
| Cd52 | NM_013706 | CD52 antigen | 1.72 | 1.28 | 1.44 |
| Fcrl3 | NM_144559 | Fc receptor-like 3 | 1.68 | 1.75 | 1.68 |
| C3 | NM_009778 | Complement component 3 | 1.63 | 1.42 | 1.39 |
| Lyzs | NM_017372 | Lysozyme | 1.45 | 0.96 | 2.28 |
| Bcl2a1a | NM_009742 | B-cell leukemia/lymphoma 2 related protein A1a | 1.39 | 1.70 | 1.94 |
| Irak3 | NM_028679 | Interleukin-1 receptor-associated kinase 3 | 1.23 | 0.78 | 0.87 |
| Igh-1a | XM_354704 | Immunoglobulin heavy chain 1a (serum IgG2a) | 1.13 | 3.89 | 7.33 |
| Psmb8 | NM_010724 | Proteosome (prosome, macropain) subunit, beta type 8 | 1.04 | 0.86 | 0.81 |
| Ii | NM_010545 | Ia-associated invariant chain | 0.99 | 1.16 | 0.95 |
| Bcl2a1b | NM_007534 | B-cell leukemia/lymphoma 2 related protein A1b | 0.98 | 1.01 | 1.84 |
| Rmcs1 | NM_207105 | Response to metastatic cancers 1 | 0.97 | 1.30 | 0.94 |
| Serpina3n | NM_009252 | Serine (or cysteine) proteinase inhibitor, clade A, member 3N | 0.92 | 2.80 | 1.37 |
| Ctss | NM_021281 | Cathepsin S | 0.86 | 0.79 | 1.88 |
| Ms4a6d | NM_026835 | Membrane-spanning 4-domains, subfamily A, member 11 | 0.86 | 0.84 | 3.15 |
| Casp1 | NM_009807 | Caspase 1 | 0.81 | 0.78 | 1.16 |
| Temt | NM_009349 | Thioether | 0.74 | 2.13 | −2.22 |
| Cd68 | NM_009853 | CD68 antigen | 0.72 | 0.67 | 1.50 |
| Ifi205 | NM_172648 | Interferon activated gene 205 | 0.70 | 0.96 | 0.64 |
| Icam1 | NM_010493 | Intercellular adhesion molecule | 0.68 | 0.98 | 0.61 |
| Fcgr3 | NM_010188 | Fc receptor, IgG, low affinity III | 0.65 | 0.61 | 1.30 |
| C1qa | NM_007572 | Complement component 1, q subcomponent, alpha polypeptide | 0.64 | 0.73 | 1.18 |
| C1qg | NM_007574 | Complement component 1, q subcomponent, gamma polypeptide | 0.64 | 0.62 | 1.16 |
| Tcrb-V8.2 | NC_000072 | T-cell receptor beta, variable 8.2 | −0.66 | 0.99 | 1.41 |
| Itm2a | NM_008409 | Integral membrane protein 2A | −0.66 | −0.79 | −0.73 |
Fig. 2STRING analysis of the overlapping age-regulated target genes. The overlapping target genes from Table 2 were analyzed together with NF-kB (Rela) to show possible interactions. The figure shows that NF-kB is potentially connected to some of our conserved age-regulated target genes (e.g. Ii, Lyz, Ctss). The use of more interaction partners in the analysis also connects several other genes to the network (e.g. the complement components and the Fc-receptors; data not shown)
List of overlapping pathways and GOs regulated with age
| Term | Brain | Heart | Kidney | |||
|---|---|---|---|---|---|---|
| Up | Down | Up | Down | Up | Down | |
|
| ||||||
| Type I Diabetes mellitus | 11 | – | 13 | – | 9 | 5 |
| Antigen processing and presentation | 15 | – | 18 | – | 13 | – |
| Cell adhesion molecules (CAMS) | 14 | – | 20 | – | 20 | – |
| Natural killer cell mediated cytotoxicity | 9 | – | – | – | 19 | – |
| Complement and coagulation cascades | 9 | – | 9 | – | – | – |
| Focal adhesion | – | – | – | 16 | 22 | – |
| Glutathione metabolism | – | – | 10 | – | – | 5 |
|
| ||||||
| Cellular physiological process | 207 | 119 | 256 | 174 | 387 | 221 |
| Localization | 84 | 45 | 92 | 59 | 131 | 80 |
| Establishment of localization | 84 | 44 | 92 | 59 | 128 | 79 |
| Regulation of programmed cell death | 16 | 9 | 15 | 11 | 28 | – |
| Protein metabolism | 67 | – | 85 | 66 | 125 | – |
| Cellular macromolecule metabolism | 65 | – | 83 | 64 | 117 | – |
| Intracellular signaling cascade | 26 | – | 33 | 22 | 52 | – |
| Programmed cell death | 19 | 10 | 20 | – | 39 | – |
| Apoptosis | 18 | 10 | 20 | – | 37 | – |
| Regulation of apoptosis | 15 | 9 | 14 | – | 27 | – |
| Vesicle-mediated transport | 12 | – | 14 | 12 | 26 | – |
| Regulation of protein metabolism | 12 | – | 11 | 8 | 14 | – |
| Response to biotic stimulus | 55 | – | 66 | – | 78 | – |
| Defense response | 51 | – | 63 | – | 74 | – |
| Immune response | 48 | – | 60 | – | 66 | – |
| Positive regulation of biological process | 24 | – | 28 | – | 42 | – |
| Death | 21 | – | 23 | – | 42 | – |
| Cell death | 20 | – | 23 | – | 41 | – |
| Antigen presentation | 18 | – | 19 | – | 14 | – |
| Antigen processing | 16 | – | 17 | – | 9 | – |
| Inflammatory response | 14 | – | 16 | – | 18 | – |
| Humoral immune response | 14 | – | 13 | – | 12 | – |
| Regulation of organismal physiological process | 13 | – | 11 | – | 21 | – |
| Behavior | 13 | – | 12 | – | 19 | – |
| Humoral defense mechanism (sensu vertebrata) | 12 | – | 10 | – | 9 | – |
| Immune cell activation | 10 | – | 11 | – | 21 | – |
| Hemopoietic or lymphoid organ development | 9 | – | 12 | – | 20 | – |
| Hemopoiesis | 9 | – | 10 | – | 15 | – |
| Endocytosis | 9 | – | 9 | – | 17 | – |
| Chemotaxis | 7 | – | 9 | – | 13 | – |
| Transport | 77 | 36 | 87 | 53 | – | 76 |
| Phosphate transport | 5 | 4 | – | 6 | – | 6 |
| Ion transport | – | 15 | – | 20 | – | 23 |
| Metal ion transport | – | 8 | – | 11 | – | 13 |
| Inorganic anion transport | – | 5 | – | 7 | – | 9 |
|
| ||||||
| Intracellular organelle | 146 | 79 | 163 | 105 | 251 | – |
| Cytoplasm | 122 | – | 118 | 61 | 141 | 105 |
| Extracellular region | 77 | – | 98 | 57 | 125 | – |
| Extracellular space | 71 | – | 91 | 47 | 115 | – |
| Plasma membrane | 51 | – | 60 | – | 94 | – |
| Cytosol | 18 | – | 14 | – | 20 | – |
| Vacuole | 13 | – | 13 | – | 13 | – |
| Lysosome | 13 | – | 11 | – | 13 | – |
| Lytic vacuole | 13 | – | 11 | – | 13 | – |
| Cell surface | 11 | – | 9 | – | 20 | – |
| Immunological synapse | 9 | – | 12 | – | 11 | – |
| Actin cytoskeleton | 8 | – | 10 | – | 16 | – |
| Endosome | 7 | – | 6 | – | 8 | – |
Fig. 3Lipid hydroperoxide (LPO) concentrations (μM) in extracts of young and aged mouse tissues. The figure shows that LPO could be detected in the aged brain, heart and kidney, but not in the corresponding young tissues. This result suggests a higher degree of oxidative stress in aged mice independent of the tissue. The concentrations of LPO were measured by the use of a standard curve method
Fig. 4ROS-mediated activation of innate immunity. The figure presents a model of ROS-mediated activation of innate immunity via the NF-kB signaling pathway. As the activation of innate immunity was shown by transcriptional analysis and the increase of oxidative stress by the measurement of LPO, the involvement of NF-kB is hypothetical and based on literature (Schreck et al. 1992; Gosselin and Abbadie 2003; Salminen et al. 2008)